Medtronic stent spurs more blood clots than rival’s

Medtronic Inc.’s new heart stent triggered more blood clots than a rival product, U.S. regulators said, raising new questions about the device’s safety days before a panel of experts weighs whether to recommend U.S. approval. The clots didn’t translate into additional deaths and heart attacks, which were lower in patients getting Medtronic’s drug-coated stent, Food and ...

Enter your user name and password in the fields above to gain access to the subscriber content on this site. Need a subscription? Click here.
Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time.
If you feel your login credentials are being used by a second party, contact customer service at 877-615-9536 for assistance in changing your password.

Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.

Forgot your password?

MLM Counties News. Notices. Need-to-know Information.

Medtronic stent spurs more blood clots than rival’s

Leave a Reply